Kinross Gold Corporation vs McKesson Corporation — how do they compare? Kinross Gold Corporation trades at $23.45 (market cap $26.63B), while McKesson Corporation trades at $832.45 (market cap $97.35B). The key difference: McKesson Corporation is far larger — about 3.7× Kinross Gold Corporation's market cap, and Kinross Gold Corporation pays the higher dividend (0.64%). Which is the better fit depends on your goals.
| KGC | MCK | |
|---|---|---|
Market Cap | $26.63B | $97.35B |
Sector | Basic Materials | Health |
52-Week High | $38.06 | $995.69 |
52-Week Low | $15.42 | $659.01 |
Enterprise Value | $25.18B | $101.98B |
Dividend Yield | 0.64% | 0.39% |
Trailing returns across standard periods
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →